Literature DB >> 1902394

Lack of a cell cycle-dependent strand bias for mutations induced in the HPRT gene by (+/-)-7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene in excision repair-deficient human cells.

R H Chen1, V M Maher, J J McCormick.   

Abstract

We showed previously that in repair-proficient human cells the location of the premutagenic lesion induced by (+-)-7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10- tetrahydrobenzo(a)pyrene (BPDE), namely, the guanine in a G.C base substitution, in mutants derived from cells treated at the beginning of S phase just when the hypoxanthine (guanine) phosphoribosyltransferase gene is replicated, differs significantly from their location in cells treated 12 h prior to the beginning of S phase (early G1 phase) (R-H. Chen et al., Proc. Natl. Acad. Sci. USA, 87:8680-8684, 1990). This suggests that the cells preferentially remove BPDE adducts from the transcribed strand. We have now determined the kinds and location of independent mutations induced by BPDE in the coding region of the hypoxanthine (guanine) phosphoribosyltransferase gene of synchronized repair-deficient xeroderma pigmentosum cells (XP12BE, complementation group A), treated at S or in G1. Nineteen of 25 mutants derived from S-treated cells and 23 of 28 mutants from G1-treated cells contained base substitutions. Eighty-nine percent of these involved a G.C base pair, primarily G.C----T.A transversions. This is similar to the kinds of mutations we saw in the repair-proficient cells. However, in contrast to our earlier results, there was no change in strand distribution of premutagenic BPDE lesions. In both populations, approximately 26% of the base substitutions involving G.C base pairs had the G located in the transcribed strand, 5 of 18 in the S phase mutants, and 5 of 21 in the G1 phase mutants. These results support the hypothesis that the strong strand bias of induced mutations observed in the repair-proficient cells results from preferential repair of BPDE-induced DNA damage from the transcribed strand.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1902394

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  REV1 accumulates in DNA damage-induced nuclear foci in human cells and is implicated in mutagenesis by benzo[a]pyrenediolepoxide.

Authors:  Suparna Mukhopadhyay; Denise R Clark; Nicholas B Watson; Wolfgang Zacharias; W Glenn McGregor
Journal:  Nucleic Acids Res       Date:  2004-11-02       Impact factor: 16.971

2.  Preferential repair and strand-specific repair of benzo[a]pyrene diol epoxide adducts in the HPRT gene of diploid human fibroblasts.

Authors:  R H Chen; V M Maher; J Brouwer; P van de Putte; J J McCormick
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

3.  REV1 is implicated in the development of carcinogen-induced lung cancer.

Authors:  Chad A Dumstorf; Suparna Mukhopadhyay; Elangovan Krishnan; Bodduluri Haribabu; W Glenn McGregor
Journal:  Mol Cancer Res       Date:  2009-01-27       Impact factor: 5.852

4.  Assessment of DNA damage and repair in specific genomic regions by quantitative immuno-coupled PCR.

Authors:  M F Denissenko; S Venkatachalam; E F Yamasaki; A A Wani
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

5.  Dose-dependent differences in the profile of mutations induced by an ultimate carcinogen from benzo[a]pyrene.

Authors:  S J Wei; R L Chang; C Q Wong; N Bhachech; X X Cui; E Hennig; H Yagi; J M Sayer; D M Jerina; B D Preston
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

6.  Site-specific rates of excision repair of benzo[a]pyrene diol epoxide adducts in the hypoxanthine phosphoribosyltransferase gene of human fibroblasts: correlation with mutation spectra.

Authors:  D Wei; V M Maher; J J McCormick
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

7.  Mutations which alter splicing in the human hypoxanthine-guanine phosphoribosyltransferase gene.

Authors:  H Steingrimsdottir; G Rowley; G Dorado; J Cole; A R Lehmann
Journal:  Nucleic Acids Res       Date:  1992-03-25       Impact factor: 16.971

8.  Mammalian assay for site-specific DNA damage processing using the human H-ras proto-oncogene.

Authors:  L Arcangeli; K J Williams
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

9.  Gene-specific and strand-specific DNA repair in the G1 and G2 phases of the cell cycle.

Authors:  L N Petersen; D K Orren; V A Bohr
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

10.  TP53 mutations induced by BPDE in Xpa-WT and Xpa-Null human TP53 knock-in (Hupki) mouse embryo fibroblasts.

Authors:  Jill E Kucab; Harry van Steeg; Mirjam Luijten; Heinz H Schmeiser; Paul A White; David H Phillips; Volker M Arlt
Journal:  Mutat Res       Date:  2015-01-30       Impact factor: 2.433

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.